Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Overview of attention for article published in The Lancet, June 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 11 X users
patent: 17 patents

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 198 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 12 news stories from 12 outlets.

In-depth analysis showing robust Diamyd® treatment effects across clinical trials to be shared at the 2024 IDS Diabetes Congress

Crwe World, 06 Nov 2024

STOCKHOLM, Nov. 6, 2024 /PRNewswire/ -- (IDS) Congress in Bruges, Belgium. The analysis will be presented at a Satellite…

In-depth analysis showing robust Diamyd® treatment effects across clinical trials to be shared at the 2024 IDS Diabetes Congress

Morning Star, 06 Nov 2024

In-depth analysis showing robust Diamyd® treatment effects across clinical trials to be shared at the 2024 IDS Diabetes…

News story from Finanz Nachrichten on Wednesday 06 November 2024

Finanz Nachrichten, 06 Nov 2024

News story from PR Newswire UK on Wednesday 06 November 2024

PR Newswire UK, 06 Nov 2024

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 8 additional news stories.